Diabetes 52:2144-2150, 2003
© 2003 by the American Diabetes Association, Inc.
Expression of Constitutively Active cGMP-Dependent Protein Kinase Prevents Glucose Stimulation of Thrombospondin 1 Expression and TGF-ß Activity
Shuxia Wang1,
Xing Wu2,
Thomas M. Lincoln3, and
Joanne E. Murphy-Ullrich1
1 Department of Pathology, Division of Molecular and Cellular Pathology, Cell Adhesion and Matrix Research Center, University of Alabama at Birmingham, Birmingham, Alabama
2 Department of Surgery, University of Alabama at Birmingham, Alabama
3 Department of Physiology, University of South Alabama, School of Medicine, Mobile, Alabama
Hyperglycemia is a crucial factor in the development of diabetic nephropathy. We previously showed that high glucose upregulates thrombospondin 1 (TSP1)-dependent transforming growth factor (TGF)-ß activation by altering cGMP-dependent protein kinase (PKG) activity as a result of decreased nitric oxide signaling. In the present study, we showed that high glucose concentrations significantly reduced endogenous PKG activity. To further examine the mechanisms by which PKG regulates TSP1 expression and TSP1-dependent TGF-ß activation, we generated stably transfected rat mesangial cells (RMCs) with inducible expression tetracycline-induced gene expression of the catalytic domain of PKG. After tetracycline induction, the catalytic domain of PKG is expressed as a cGMP-independent active kinase. Expression of the catalytic domain prevented high glucose-mediated increases in transcription of the TSP1 gene with no alteration in TSP1 mRNA stability. Glucose stimulation of TSP1 protein expression and TGF-ß bioactivity were also downregulated. TGF-ß-dependent fibronectin and type IV collagen expression under high glucose conditions were significantly reduced upon catalytic domain expression in transfected RMCs. These results show that constitutively active PKG inhibits the fibrogenic potential of high glucose through repression of TSP1-dependent TGF-ß bioactivity, suggesting that gene transfer of the catalytic domain of PKG might provide a new strategy for treatment of diabetic renal fibrosis.
Address correspondence and reprint requests to Joanne E. Murphy-Ullrich, Department of Pathology, University of Alabama at Birmingham, Volker Hall 668, 1670 University Blvd., Birmingham, AL 35294-0019. E-mail: murphy{at}path.uab.edu

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. Peng, D. Wu, B. Gao, A. J. Ingram, B. Zhang, K. Chorneyko, R. McKenzie, and J. C. Krepinsky
RhoA/Rho-Kinase Contribute to the Pathogenesis of Diabetic Renal Disease
Diabetes,
June 1, 2008;
57(6):
1683 - 1692.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Daniel, K. Schaub, K. Amann, J. Lawler, and C. Hugo
Thrombospondin-1 Is an Endogenous Activator of TGF-{beta} in Experimental Diabetic Nephropathy In Vivo
Diabetes,
December 1, 2007;
56(12):
2982 - 2989.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Kaun, C. A. L. Riedl, M. Chakaborty-Chatterjee, A. T. Belay, S. J. Douglas, A. G. Gibbs, and M. B. Sokolowski
Natural variation in food acquisition mediated via a Drosophila cGMP-dependent protein kinase
J. Exp. Biol.,
October 15, 2007;
210(20):
3547 - 3558.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Raman, I. Krukovets, T. E. Marinic, P. Bornstein, and O. I. Stenina
Glycosylation Mediates Up-regulation of a Potent Antiangiogenic and Proatherogenic Protein, Thrombospondin-1, by Glucose in Vascular Smooth Muscle Cells
J. Biol. Chem.,
February 23, 2007;
282(8):
5704 - 5714.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Saura, C. Zaragoza, B. Herranz, M. Griera, L. Diez-Marques, D. Rodriguez-Puyol, and M. Rodriguez-Puyol
Nitric Oxide Regulates Transforming Growth Factor-{beta} Signaling in Endothelial Cells
Circ. Res.,
November 25, 2005;
97(11):
1115 - 1123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-S. Huang, L.-Y. Chuang, J.-Y. Guh, C.-J. Chen, Y.-L. Yang, T.-A. Chiang, M.-Y. Hung, and T.-N. Liao
Effect of Nitric Oxide-cGMP-Dependent Protein Kinase Activation on Advanced Glycation End-Product-Induced Proliferation in Renal Fibroblasts
J. Am. Soc. Nephrol.,
August 1, 2005;
16(8):
2318 - 2329.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ihara, S. Manabe, M. Kanda, H. Kawano, T. Nakayama, I. Sekine, T. Kondo, and Y. Ito
Increased expression of protein C-mannosylation in the aortic vessels of diabetic Zucker rats
Glycobiology,
April 1, 2005;
15(4):
383 - 392.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Wang, J. Skorczewski, X. Feng, L. Mei, and J. E. Murphy-Ullrich
Glucose Up-regulates Thrombospondin 1 Gene Transcription and Transforming Growth Factor-{beta} Activity through Antagonism of cGMP-dependent Protein Kinase Repression via Upstream Stimulatory Factor 2
J. Biol. Chem.,
August 13, 2004;
279(33):
34311 - 34322.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Diabetes Association.
|
|
| |
|